Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
FTXH
51
HOLDINGS
27%
ALSO IN BBH
BBH
26
HOLDINGS
54%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus BBH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in BBH |
Overlap | |
|---|---|---|---|---|
 |
REGENERON PHARMACEUTICALS | 3.9% | 7.6% | 3.9% |
|
GILEAD SCIENCES INC | 3.9% | 17.2% | 3.9% |
|
AMGEN INC | 3.8% | 17.1% | 3.8% |
|
VERTEX PHARMACEUTICALS INC | 3.6% | 9.6% | 3.6% |
|
UNITED THERAPEUTICS CORP | 3.6% | 3.3% | 3.3% |
FTXH Overweight Relative to BBH
|
MERCK & CO. INC. | 8.3% |
|
JOHNSON & JOHNSON | 8.2% |
|
BRISTOL-MYERS SQUIBB CO | 7.6% |
|
PFIZER INC | 6.5% |
|
ABBVIE INC | 6.3% |
|
CARDINAL HEALTH INC | 4.4% |
|
ELI LILLY & CO | 4.1% |
|
VIATRIS, INC. | 3.9% |
 |
JAZZ PHARMACEUTICALS PLC | 2.5% |
|
ZOETIS INC | 2.2% |
FTXH Underweight Relative to BBH
|
GILEAD SCIENCES INC | -13.4% |
|
AMGEN INC | -13.3% |
|
VERTEX PHARMACEUTICALS INC | -6.0% |
 |
ARGENX SE ADR | -4.0% |
|
REGENERON PHARMACEUTICALS | -3.7% |
|
NATERA INC | -3.6% |
|
IQVIA HOLDINGS INC | -3.4% |
|
ALNYLAM PHARMACEUTICALS INC | -3.3% |
|
BEIGENE LTD. SPONSORED ADR | -3.0% |
|
INSMED INC | -2.9% |